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Abstract 
 
Introduction: Secondary bladder neck sclerosis (BNS) represents one of the most common long-term complications after prostate 
surgical treatment. In this retrospective study, we aimed to evaluate our initial experience concerning the bipolar plasma vaporization 
(BPV) performed in patients with secondary BNS and to assess the efficiency, safety and short-term postoperative results of this 
approach. 
Materials & Methods: Between May 2009 and May 2010, a total of 30 male patients with BNS underwent BPV and were followed 
for a period of 6 months. BNS was secondary to monopolar transurethral resection of prostate (TURP) in 19 cases, to open surgery 
for BPH (open prostatectomy) in 8 cases and to radical prostatectomy for prostate cancer in 3 cases. The follow-up protocol included 
the International Prostate Symptom Score (IPSS), quality of life score (QoL), maximum flow rate (Qmax) and post-voiding residual 
urinary volume (RV) evaluated at 1, 3 and 6 months after surgery. 
Results: BPV was successfully performed in all cases. All patients were able to void spontaneously and were continent after 
catheter removal. The mean operating time was 9 minutes, the mean catheterization period was 18 hours and the mean hospital 
stay was 24 hours. Preoperatively and at 1, 3 and 6 months after surgery, the mean values for Qmax and RV were 7.2 ml/s and 110 
ml, 23.9 ml/s and 20 ml, 23.8 ml/s and 28 ml, and 23.4 ml/s and 26 ml, respectively. Before surgery and at 1, 3 and 6 months, the 
IPSS and QoL scores were 22.6 and 4.1, 3.4 and 1.2, 3.6 and 1.4, and 3.7 and 1.4, respectively. 
Conclusions:  BPV represents a valuable endoscopic treatment alternative for secondary BNS with good efficacy, reduced 
morbidity, fast postoperative recovery and satisfactory follow-up parameters. 
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Abbreviations 
BNS – bladder neck sclerosis, BPV – bipolar plasma vaporization, TURP – transurethral resection of the prostate, IPSS – 
International Prostate Symptom Score, QoL – quality of life score, Qmax – maximum flow rate, RV – post-voiding residual urinary 
volume  
Introduction 
Secondary bladder neck sclerosis (BNS) 
represents one of the most common long-term 
complications after the surgical treatment of the prostate. 
According to the EAU Guidelines, the risk of developing 
this pathology is 4% after TURP, 1.8% after open surgery 
for BPH and 0.5-14.6% after radical prostatectomy for 
prostate cancer [1]. 
BNS management includes periodic dilation, 
bladder neck incision, standard monopolar transurethral 
resection of the fibrous tissue and various laser 
treatments. [2] 
During the recent years, various authors 
presented the bipolar electro-surgical technology as a 
promising alternative for these patients. 
A new development of this technique, the bipolar 
plasma vaporization (BPV) using the TURis (transurethral 
resection in saline) system was recently introduced in 
clinical practice. The equipment used for this approach 
includes the Olympus UES-40 Surgmaster generator 
(Olympus, Hamburg, Germany), the OES Pro bipolar 
resectoscope and the “mushroom” vapo-resection 
electrode.   
In May 2009, we performed this procedure in the 
“Sf. Ioan” Clinical Emergency Hospital, Department of 
Urology as a national premiere in BPH treatment. 
Subsequently, the technique was also applied in large 
non-muscle invasive bladder tumors as well as in BNS 
patients.  Journal of Medicine and Life Vol. 5, Issue 1, January‐March 2012 
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In this retrospective study, we aimed to evaluate 
our initial experience concerning BPV performed in cases 
of secondary BNS and to assess the efficiency, safety 
and short-term postoperative results of this approach. 
Materials and methods 
Between May 2009 and May 2010, a total of 30 
male patients with a mean age of 71 (range 51 to 89 
years old) and secondary BNS underwent BPV and were 
followed for a period of 6 months.  
BNS was secondary to monopolar TURP in 19 
cases, to open surgery for BPH (open prostatectomy) in 8 
cases and to radical prostatectomy for prostate cancer in 
3 cases. In this last category of patients, there were no 
signs of local recurrence. 
Preoperatively, the investigation protocol 
included digital rectal examination, blood tests, PSA, urine 
culture, International Prostate Symptom Score (IPSS), 
quality of life (QoL) score, maximum flow rate (Qmax), 
abdominal ultrasonography, post-voiding residual urinary 
volume (RV) and retrograde uretrography. The inclusion 
criteria were represented by Qmax < 10 ml/s and IPSS > 
19. 
The plasma vaporization was successfully 
performed under spinal anesthesia and using saline 
continuous flow irrigation. (Fig. 1) 
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The spherical shape new type of electrode 
displaying a plasma corona on its surface was gradually 
moved in direct contact with the fibrous tissue (the 
“hovering” technique), thus producing a virtually blood-
less vaporization at 320 W (Fig. 2).  
 
 
 
 
 
Fig. 1 – Pre- and postoperative images of the prostatic fossa Journal of Medicine and Life Vol. 5, Issue 1, January‐March 2012 
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Several tissue fragments were resected from the bladder neck area for the pathological analysis in all prostate 
cancer cases. (Fig. 3) 
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Fig. 2 – Bipolar plasma vaporization of the fibrous tissue at the bladder neck 
Fig. 3 – Resection biopsy in bladder neck sclerosis secondary to radical prostatectomy Journal of Medicine and Life Vol. 5, Issue 1, January‐March 2012 
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All patients were evaluated at 1, 3 and 6 months 
after surgery by IPSS and QoL scores, Qmax and RV. 
Control retrograde urethrography and abdominal 
ultrasonography were performed at 6 months in all cases. 
Results 
BPV was successfully performed in all cases. 
There were no major intra- or postoperative 
complications. During all procedures, blood loss was 
insignificant and no patient required blood transfusions. 
Also, there were no cases of urinary tract infection or 
sepsis, profound thermal lesions, significant postoperative 
bleeding or clot retention.  
All patients were able to void spontaneously and 
were continent after catheter removal. On the other hand, 
four patients presented moderate irritative symptoms 
(mainly dysuria, urgency and frequency) and were treated 
conservatively, with no further complications. In all 
prostate cancer cases, the pathological specimens were 
negative for malignancy. 
The mean operating time was 9 minutes (range 
5 to 22 minutes), the mean catheterization period was 18 
hours (range 12 to 24 hours) and the mean hospital stay 
was 24 hours (range 18 to 36 hours). 
Preoperatively and at 1, 3 and 6 months after 
surgery, the mean values for Qmax, were 6.2 ml/s, 23.9 
ml/s, 23.8 ml/s and 23.4 ml/s, respectively. At the same 
moments, the mean RV was 110 ml, 20 ml, 28 ml and 26 
ml, respectively. (Table 1) There were no aspects 
suggestive for re-stenosis at the 6 months’ retrograde 
urethrography. 
 
Table 1. Pre- and postoperative parameters 
Mean  Preoperative  At 1 month  At 3 months  At 6 months 
Qmax  6.2 ml/s (range 3-9.8 ml/s)  23.9 ml/s (range 20.1-
27.2 ml/s) 
23.8 ml/s (range 19.7-
26.8 ml/s) 
23.4 ml/s (range 19.5 - 
27.1 ml/s) 
RV  110 ml (range 45-230ml)  20 ml (range 0- 55 ml)  28 ml (range 0- 65 ml)  26  ml (0-60 ml) 
IPSS  22.6 (range 20-27)  3.4 (range 2-6)  3.6 (range 2-7)  3.7 (range 2-7) 
QoL  4.1 (range 3-5)  1.2 (range 1-2)  1.3 (range 1-2)  1.3 (range 1-2) 
 
As far as symptom scores were concerned, 
before surgery, the IPSS and QoL scores were 22.6 and 
4.1. During the follow-up, these scores decreased at 1, 3 
and 6 months to 3.4 and 1.2, 3.6 and 1.3, and 3.7 and 
1.3, respectively. (Table 1) 
Discussion 
Secondary BNS still remains an important 
problem in modern urology. In a study by Ying-Huei Lee 
et al. on 1135 patients which underwent standard TURP, 
9.7% of patients developed BNS during a mean follow-up 
period of 37 months. Small prostates were initially 
diagnosed in most of these cases [3].  
In another trial by Al-Singary et al. on 900 
patients, over a 4-year follow-up period after monopolar 
TURP, 3.4% of patients developed BNS, with a mean 
resected prostatic tissue weight of 11 +/- 3.7 g. [4]  
The retrograde endoscopic approach represents 
the main alternative in the treatment of this type of 
complication. [5] 
Bipolar plasma vaporization is a relatively new 
technique, at the beginning as part of the therapeutic 
armamentarium for lower urinary tract pathology. Despite 
gaining an increasing acknowledgement as a reliable tool 
for BPH [6, 7] and large non-muscle invasive bladder 
tumors [8] treatment, the use of this method in BNS 
patients was not yet evaluated in clinical trials.  
According to our experience so far and to the 
results of the present study, there are some important 
advantages provided by BPV in the treatment of 
secondary BNS.  
Subjectively, this type of vaporization did not 
alter the visual characteristics of the tissues, thus 
enabling the surgeon to differentiate the fibrous tissue and 
the muscular fibers of the prostatic capsula with increased 
accuracy.  
Technically, the basis of BPV is represented by 
the ability of the UES-40 bipolar electrosurgical generator 
to produce a plasma corona on the surface of the 
spherical shape “mushroom” type electrode. Plasma 
vaporization occurs by direct gentle contact with the 
tissue surface and performs concomitant hemostasis. 
The power of the generator can be adapted to 
tissue characteristics and consistency, thus providing the 
surgeon with additional technical flexibility: 320 W for 
fibrous tissue, 280-290 W for the average BPH tissue, 
240 W for remaining BPH small fragments close to the 
capsula or apex and 120-140 W for coagulation. In 
secondary BNS cases, due to the increased consistency 
of the scar tissue, a power of 320 W was used during all 
procedures. This feature provided fast removal of large 
fibrotic areas. 
Due to the lack of bleeding, visibility remained 
excellent throughout the procedure. The vaporization area 
emphasized a remarkably smooth surface and sharp 
margins, with no irregularities or debris and no 
supplementary thermal lesions of the subjacent tissue. 
(Fig. 4) 
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The postoperative aspects of the prostatic fossa 
revealed a large passage, without obstruction, in every 
case. It is also important to mention that there were no 
major intra- or postoperative complications, which 
confirms the safety of the procedure. Another advantage 
of this technique was represented by the possibility to 
perform resection biopsy in cases of previous history of 
prostate cancer by simple changing of the electrode, thus 
providing a certain pathological analysis for these patients 
and good functional results. (Fig. 5) 
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As far as the mean operating time was 
concerned, BPV was superior to PlasmaKineticTM bipolar 
vaporization [2] (9 versus 15 minutes) and similar to laser 
incision [9] (9 versus 7 minutes), thus proving its’ 
effectiveness in terms of fast scar tissue removal.  
Objectively, our follow-up results seem 
satisfactory by comparison to the literature data. In a 
study by Basok et al., secondary BNS patients underwent 
bipolar vaporization using the PlasmaKineticTM system, a 
precursor of TURis, after a mean follow-up period of 12.2 
months, Qmax increased from 3.4 ml/s before surgery to 
16.2 ml/s. [2] In our trial, despite the shorter follow-up 
period, progresses in terms of Qmax were substantial: from 
the preoperative value of 6.2 ml to 23.4 ml/s at 6 months. 
As far as the TURis system is concerned, in a 
trial by Sevriukov et al. in which only bipolar resection was 
performed, RV decreased from a mean preoperative 
value of 92.3 ml to a maximum of 35 ml after surgery, 
Qmax increased from 8.1 ml/s to 19.8 ml/s and IPSS was 
reduced from 20.8 to 7.5. [4]  
From this perspective, we can say that plasma 
vaporization constitutes a promising application of the 
TURis system. Our series emphasized remarkable 
improvements, as the mean RV decreased from 110 ml to 
26 ml at 6 months and progresses in terms of Qmax and 
IPSS were significant – Qmax increased from 6.2 ml/s to 
23.4 ml/s and IPSS decreased from 22.6 to 3.7. 
Also, BPV seems comparable to laser incision as 
well. According to a study by Bach et al. in which 14 
patients underwent 2-micron continuous wave laser 
Fig. 4 – Final aspect of the bladder neck after plasma vaporization 
Fig. 5 – Post- radical prostatectomy bladder neck, before and after bipolar plasma vaporization and resection Journal of Medicine and Life Vol. 5, Issue 1, January‐March 2012 
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incision, Qmax increased from 9 ml/s before surgery to 23 
ml/s after a 12 months follow-up. The symptom score and 
QoL score improved from 22 to 8 and from 4 to 1, 
respectively. [9] It is obvious that our results match these 
figures, thus proving the efficacy of BPV. On the other 
hand, the bipolar technology appears to be more 
advantageous in terms of costs by comparison to laser 
treatment. [2] 
Regarding the long-term complications, the re-
stenosis rate after endoscopic BNS treatment remains 
significant according to the literature data, regardless of 
the applied technique: 13.7% for standard resection [5] 
and 27.5% for monopolar incision of the bladder neck [4]. 
According to published studies, an important 
advantage of the fibrous tissue instant bipolar 
vaporization is that it contributes to a decreased recurrent 
scar tissue formation [2]. Also, laser incision was 
presented to provide disintegration of the fibrous area and 
secondary reepithelization without scarring. [10] 
Due to our rather short follow-up period, it may 
be too early to make a statement in this regard 
concerning TURis plasma vaporization. However, since 
there were no urethrographic images suggestive of re-
stenosis at 6 months and the progresses in terms of 
follow-up parameters remained constant, BPV seems to 
confirm the ability of preventing recurrent fibrosis. This 
aspect may constitute an interesting endpoint for future 
studies.  
Conclusions 
We may conclude that BPV represents a 
valuable alternative in the treatment of secondary BNS, 
with very good efficacy good efficacy, reduced morbidity, 
fast postoperative recovery and satisfactory follow-up 
parameters.  
The reduced operating time, catheterization 
period and hospital stay, as well as the significant 
postoperative improvements in terms of Qmax, RV, IPSS 
and QoL score are important advantages of this new 
technique. 
In all these regards, the outcome of BPV 
compares favorably to monopolar resection or incision, 
bipolar vaporization or resection as well as to laser 
incision. 
Regarding the re-stenosis rate, BPV seems quite 
promising but additional extensive studies are required in 
order to confirm this aspect. Therefore, the long-term 
results and general viability of the method remain to be 
established.  
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